Importance of cytokeratin-20 expression in papillary urothelial neoplasia
Abstract
Purpose: The aim of this study is to determine the role of Cytokeratin 20 (CK20) expression in the diagnosis of papillary urothelial neoplasms of the bladder, and its relationship with histological grade, recurrence and other prognostic factors.
Materials and Methods: Patients diagnosed with papillary urothelial neoplasm of bladder transurethral resection (TUR) specimens between January 2011 and December 2016 were retrospectively analyzed. Of the 136 selected patients, 32 (24%) were diagnosed with urothelial papilloma, 8 (6%) with papillary urothelial neoplasm of low malignant potential (PUNLMP), 36 (26%) with low grade non-invasive papillary urothelial carcinoma (LGNIPUC), 12 (9%) with high grade non-invasive papillary urothelial carcinoma (HGNIPUC) and 48 (35%) were diagnosed with high grade invasive papillary urothelial carcinoma (HGIPUC). There was no patient diagnosed with LGIPUC. The correlation between CK20 expression and histological grade, tumor recurrence, presence of progression and presence/absence of invasion was investigated.
Results: There was a significant difference between PUNLMP and LGNIPUK in terms of CK20 expression in favor of LGNIPUK. Also there was a significant correlation between histological grade, presence of invasion, recurrence, progression and CK20 expression in patients diagnosed with Papillary Urothelial Neoplasm.
Conclusion: This study supports that CK20 is an important marker in the differentiation between PUNLMP and LGNIPUC, as well as in the determination of histological grade in urothelial carcinomas.
Keywords
Papillary Urothelial Neoplasm , CK20 Expression , Prognostic Markers
Kaynakça
- 1- Moch H, Humphrey PA, Ulbright TM, Reuter VE. Tumours of the urinary tract. In: Moch H, Humphrey PA, Ulbright TM, Reuter VE, Editor. WHO Classification of Tumours of the Urinary System and Male Genital Organs, 4th ed. Lyon, France: IARC Press; 2016. p.77-106.
- 2- Arias-Stella JA, Shah AB, Gupta NS, Williamson SR. CK20 and p53 Immunohistochemical Staining Patterns in Urinary Bladder Specimens with Equivocal Atypia. Arch Pathol Lab Med. 2018; 142:64-9.
- 3- Cheng L, Cheville JC, Neumann RM, Leibovich BC, Egan KS, Spotts BE et al. Survival of patients with carcinoma in situ of the urinary bladder. Cancer. 1999; 85: 2469-74.
- 4- Ogata DC, Marcondes CA, Tuon FF, Busato WF Jr, Cavalli G, Czeczko LE. Superficial papillary urothelial neoplasms of the bladder (PTA E PT1): correlation of expression of P53, KI-67 and CK20 with histologic grade, recurrence and tumor progression. Rev Col Bras Cir. 2012; 39: 394-400.
- 5- Wang G, McKenney JK. Urinary Bladder Pathology: World Health Organization Classification and American Joint Committee on Cancer Staging Update. Arch Pathol Lab Med. 2019; 143: 571-7.
- 6- Mallofr´e C, Castillo M, Morente V, Sol ´e M. Immunohistochemical expression of CK20, p53, and Ki-67 as objective markers of urothelial dysplasia. Mod Pathology 2003; 16: 187–91.
- 7- Alsheikh A, Mohamedali Z, Jones E, Masterson J, Gilks CB. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology. Mod Pathol. 2001; 14: 267-72.
- 8- Moll R. Molecular diversity of cytokeratin: significance for cell and tumor differentiation. Acta Histochem Suppl. 1991; 4:117–27.
- 9- Harnden P, Eardley I, Joyce AD, Southgate J. Cytokeratin 20 as an objective marker of urothelial dysplasia. Br J Urol. 1996; 78: 870–5.
- 10- Rajcani J, Kajo K, Adamkov M, Moravekova E, Lauko L, Felcanova D et al. Immunohistochemical characterization of urothelial carcinoma. Bratisl Lek Listy. 2013; 114: 431-8.
